Combination with Methotrexate and Cyclophosphamide Attenuated Maturation of Dendritic Cells: Inducing Treg Skewing and Th17 Suppression In Vivo

Table 2

BMDC surface antigen’s expression of OVA group.

Week	𝑛	BMDC surface antigen’s expression (𝑋±𝑆, %)
		CD11c	CD40	CD80	CD86	MHC-II
0	6	87.85±4.51	69.72±4.70	89.78±3.67	79.37±3.60	84.32±2.81
3	5	88.50±3.71	69.40±3.82	89.10±2.75	78.90±4.63	83.82±4.19
6	4	86.18±4.25	68.25±2.86	88.13±3.18	77.88±2.61	82.55±3.02
9	5	85.60±3.41	67.40±3.56	87.20±2.87	76.70±2.97	81.50±3.11

Values are expressed as mean ± standard deviation; the difference among groups was determined by ANOVA analysis and comparison between two groups was analyzed by the t-test.
No significant difference among different time of administration (𝑃>0.05).